• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黑素皮质素系统在炎症性肠病中的作用:对其机制和治疗潜力的深入了解。

The Melanocortin System in Inflammatory Bowel Diseases: Insights into Its Mechanisms and Therapeutic Potentials.

机构信息

Hepatogastroenterology Unit, Department of Precision Medicine, University of Campania Luigi Vanvitelli, 80138 Naples, Italy.

Mental Health Department, S. Pio Hospital, Via dell'Angelo, 82100 Benevento, Italy.

出版信息

Cells. 2023 Jul 19;12(14):1889. doi: 10.3390/cells12141889.

DOI:10.3390/cells12141889
PMID:37508552
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10378568/
Abstract

The melanocortin system is a complex set of molecular mediators and receptors involved in many physiological and homeostatic processes. These include the regulation of melanogenesis, steroidogenesis, neuromodulation and the modulation of inflammatory processes. In the latter context, the system has assumed importance in conditions of chronic digestive inflammation, such as inflammatory bowel diseases (IBD), in which numerous experiences have been accumulated in mouse models of colitis. Indeed, information on how such a system can counteract colitis inflammation and intervene in the complex cytokine imbalance in the intestinal microenvironment affected by chronic inflammatory damage has emerged. This review summarises the evidence acquired so far and highlights that molecules interfering with the melanocortin system could represent new drugs for treating IBD.

摘要

黑皮质素系统是一个复杂的分子介质和受体系统,参与许多生理和内稳态过程。这些过程包括黑色素生成、类固醇生成、神经调节和炎症过程的调节。在后一种情况下,该系统在慢性消化炎症的情况下变得重要,例如炎症性肠病 (IBD),在这种情况下,已经在结肠炎的小鼠模型中积累了大量经验。事实上,关于该系统如何对抗结肠炎炎症以及干预受慢性炎症损伤影响的肠道微环境中复杂的细胞因子失衡的信息已经出现。这篇综述总结了迄今为止获得的证据,并强调干扰黑皮质素系统的分子可能成为治疗 IBD 的新药。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b943/10378568/84f10d766d08/cells-12-01889-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b943/10378568/7b76d5952a85/cells-12-01889-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b943/10378568/84f10d766d08/cells-12-01889-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b943/10378568/7b76d5952a85/cells-12-01889-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b943/10378568/84f10d766d08/cells-12-01889-g002.jpg

相似文献

1
The Melanocortin System in Inflammatory Bowel Diseases: Insights into Its Mechanisms and Therapeutic Potentials.黑素皮质素系统在炎症性肠病中的作用:对其机制和治疗潜力的深入了解。
Cells. 2023 Jul 19;12(14):1889. doi: 10.3390/cells12141889.
2
Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease.源自促黑素细胞激素的三肽KPV在炎症性肠病的小鼠模型中具有抗炎潜力。
Inflamm Bowel Dis. 2008 Mar;14(3):324-31. doi: 10.1002/ibd.20334.
3
Melanocortins and cardiovascular regulation.促黑素与心血管调节。
Eur J Pharmacol. 1998 Oct 30;360(1):1-14. doi: 10.1016/s0014-2999(98)00615-3.
4
ACTH: The forgotten therapy.促肾上腺皮质激素:被遗忘的疗法。
Semin Immunol. 2015 May;27(3):216-26. doi: 10.1016/j.smim.2015.02.003. Epub 2015 Feb 26.
5
Analysis of the Therapeutic Effect of Changyanning on Intestinal Flora in Inflammatory Bowel Disease.肠安宁对炎症性肠病肠道菌群影响的疗效分析。
Contrast Media Mol Imaging. 2022 Jun 22;2022:3757763. doi: 10.1155/2022/3757763. eCollection 2022.
6
Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.通过RAND方法评估炎症性肠病中免疫抑制药物的适用性:意大利炎症性肠病研究小组(IG-IBD)立场声明
Dig Liver Dis. 2005 Jun;37(6):407-17. doi: 10.1016/j.dld.2004.12.013.
7
Intestinal immunomodulation. Role of regulative peptides and promising pharmacological activities.肠道免疫调节。调节肽的作用及潜在药理活性。
Curr Pharm Des. 2008;14(1):71-95. doi: 10.2174/138161208783330745.
8
Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.用于研究正常和炎症状态下人结肠上皮细胞代谢与免疫功能的体外模型的开发、验证及应用
Dan Med J. 2015 Jan;62(1):B4973.
9
Inflammatory cytokines: from discoveries to therapies in IBD.炎症细胞因子:从发现到 IBD 的治疗。
Expert Opin Biol Ther. 2019 Nov;19(11):1207-1217. doi: 10.1080/14712598.2019.1652267. Epub 2019 Aug 8.
10
Biologic therapy for inflammatory bowel disease.炎症性肠病的生物治疗
Drugs. 2005;65(16):2253-86. doi: 10.2165/00003495-200565160-00002.

引用本文的文献

1
Association Between Caffeine Intake and Bowel Habits and Inflammatory Bowel Disease: A Population-Based Study.咖啡因摄入量与肠道习惯及炎症性肠病之间的关联:一项基于人群的研究。
J Multidiscip Healthc. 2025 Jun 27;18:3717-3726. doi: 10.2147/JMDH.S512855. eCollection 2025.
2
A Randomized Double-Blind, Placebo-Controlled Trial of Artesunate and Curcumin in Patients With Crohn's Disease: A Pilot Study.青蒿琥酯与姜黄素治疗克罗恩病患者的随机双盲、安慰剂对照试验:一项初步研究
JGH Open. 2025 Jun 29;9(7):e70211. doi: 10.1002/jgh3.70211. eCollection 2025 Jul.
3
Intestinal Fibrosis in Crohn's Disease: Pathophysiology, Diagnosis, and New Therapeutic Targets.

本文引用的文献

1
Acthar Gel (RCI): A Narrative Literature Review of Clinical and Economic Evidence.促肾上腺皮质激素凝胶(RCI):临床与经济学证据的叙述性文献综述
Clinicoecon Outcomes Res. 2023 Jun 26;15:499-512. doi: 10.2147/CEOR.S410082. eCollection 2023.
2
A Narrative Review of Acthar Gel for the Treatment of Myositis.关于曲安西龙凝胶治疗肌炎的叙述性综述。
Rheumatol Ther. 2023 Jun;10(3):523-537. doi: 10.1007/s40744-023-00545-1. Epub 2023 Mar 26.
3
A novel oral formulation of the melanocortin-1 receptor agonist PL8177 resolves inflammation in preclinical studies of inflammatory bowel disease and is gut restricted in rats, dogs, and humans.
克罗恩病中的肠道纤维化:病理生理学、诊断及新治疗靶点
J Clin Med. 2025 Jun 8;14(12):4060. doi: 10.3390/jcm14124060.
4
An Assessment of the Nutritional Status in Patients with Inflammatory Bowel Disease-A Matched-Pair Case-Control Study.炎症性肠病患者营养状况评估——一项配对病例对照研究。
Nutrients. 2025 Apr 17;17(8):1369. doi: 10.3390/nu17081369.
5
Right-Sided Dysplasia in Inflammatory Bowel Disease Is Not Associated with Conventional Risk Factors for Neoplasia.炎症性肠病中的右侧发育异常与肿瘤形成的传统危险因素无关。
Gastroenterol Insights. 2025 Jun;16(2). doi: 10.3390/gastroent16020014. Epub 2025 Apr 7.
6
Serum Maresin-1 and Resolvin-D1 Levels as Non-Invasive Biomarkers for Monitoring Disease Activity in Ulcerative Colitis.血清maresin-1和resolvin-D1水平作为监测溃疡性结肠炎疾病活动的非侵入性生物标志物。
Diagnostics (Basel). 2025 Mar 25;15(7):834. doi: 10.3390/diagnostics15070834.
7
Cholangioscope-assisted ERAT for the diagnoses and treatment of ulcerative colitis with appendiceal orifice inflammation: a case report and a literature review.经胆道镜辅助逆行阑尾治疗术诊断和治疗伴有阑尾开口炎症的溃疡性结肠炎:一例病例报告及文献综述
Int J Colorectal Dis. 2025 Apr 8;40(1):89. doi: 10.1007/s00384-025-04884-z.
8
Evidence Report on the Safety of Gastrointestinal Endoscopy in Patients on Glucagon-like Peptide-1 Receptor Agonists: A Systematic Review and Meta-Analysis.胰高血糖素样肽-1受体激动剂治疗患者胃肠道内镜检查安全性的证据报告:系统评价与荟萃分析
Diagnostics (Basel). 2025 Mar 19;15(6):770. doi: 10.3390/diagnostics15060770.
9
Management of Atherosclerotic Cardiovascular Risk in Inflammatory Bowel Disease: Current Perspectives.炎症性肠病中动脉粥样硬化性心血管风险的管理:当前观点
Adv Ther. 2025 May;42(5):2118-2134. doi: 10.1007/s12325-025-03154-2. Epub 2025 Mar 27.
10
Research Status and Trends of Gut Microbiota and Intestinal Diseases Based on Bibliometrics.基于文献计量学的肠道微生物群与肠道疾病研究现状及趋势
Microorganisms. 2025 Mar 17;13(3):673. doi: 10.3390/microorganisms13030673.
一种新型口服黑素皮质素-1 受体激动剂 PL8177 在炎症性肠病的临床前研究中可缓解炎症,且在大鼠、犬和人中具有肠道限制性。
Front Immunol. 2023 Feb 20;14:1083333. doi: 10.3389/fimmu.2023.1083333. eCollection 2023.
4
Dysregulation of the immune response in TGF-β signalopathies.TGF-β 信号通路中免疫反应失调。
Front Immunol. 2022 Dec 9;13:1066375. doi: 10.3389/fimmu.2022.1066375. eCollection 2022.
5
Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl syndrome and Alström syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label period.促黑素细胞激素 4 受体激动剂赛麦兰肽治疗 Bardet-Biedl 综合征和 Alström 综合征患者的疗效和安全性:一项多中心、随机、双盲、安慰剂对照、有开放标签期的 3 期临床试验。
Lancet Diabetes Endocrinol. 2022 Dec;10(12):859-868. doi: 10.1016/S2213-8587(22)00277-7. Epub 2022 Nov 7.
6
PubChem 2023 update.PubChem 2023 更新。
Nucleic Acids Res. 2023 Jan 6;51(D1):D1373-D1380. doi: 10.1093/nar/gkac956.
7
Influence of diabetes mellitus on inflammatory bowel disease course and treatment outcomes. A systematic review with meta-analysis.糖尿病对炎症性肠病病程及治疗结果的影响。一项系统评价与荟萃分析。
Dig Liver Dis. 2023 May;55(5):580-586. doi: 10.1016/j.dld.2022.08.017. Epub 2022 Sep 1.
8
Obesity and gut-microbiota-brain axis: A narrative review.肥胖与肠道微生物群-脑轴:叙事性综述。
J Clin Lab Anal. 2022 May;36(5):e24420. doi: 10.1002/jcla.24420. Epub 2022 Apr 14.
9
The Lesson from the First Italian Lockdown: Impacts on Anxiety and Depressive Symptoms and Sleep Quality in Patients with Remission of Inflammatory Bowel Disease.首次意大利封锁的教训:对炎症性肠病缓解患者的焦虑、抑郁症状和睡眠质量的影响。
Rev Recent Clin Trials. 2022;17(2):109-119. doi: 10.2174/1574887117666220328125720.
10
Depression and Inflammatory Bowel Disease: A Bidirectional Two-sample Mendelian Randomization Study.抑郁与炎症性肠病:一项双向二样本孟德尔随机化研究。
J Crohns Colitis. 2022 May 10;16(4):633-642. doi: 10.1093/ecco-jcc/jjab191.